Literature DB >> 19614866

Understanding measurements of intestinal permeability in healthy humans with urine lactulose and mannitol excretion.

M Camilleri1, A Nadeau, J Lamsam, S Linker Nord, M Ryks, D Burton, S Sweetser, A R Zinsmeister, R Singh.   

Abstract

Our aim was to understand the information from differential two-sugar excretion (2-SE) in measuring intestinal permeability. In a crossover study in 12 healthy volunteers, we compared urinary excretion ratios of lactulose (L) to mannitol [(M) LMR] after ingestion in liquid formulation (LF) or in delayed-release, methacrylate-coated capsules (CAP). Both formulations were radiolabelled. Urine was collected every 2 h from 0 to 8 h, and from 8 to 24 h. Two hours after LF, gastric residual was 15.9 +/- 6.2% (SEM), and the percentage in colon was 49.6 +/- 7.8%; in 11/12 participants, liquid had entered colon within 2 h. Average CAP arrival time in colon was 5.16 +/- 0.46 h (mode 6 h). After LF, mannitol was extensively absorbed in the first 8 h; lactulose absorption was low throughout the 24 h. After the LF, the LMR (geometric mean, 95% CI per h) in the 0-2 h urine was [0.08 (0.05, 0.11)], which was lower than in 8-24 h urine [0.32 (0.16, 0.46); P < 0.05]. Urine LMRs at 8-24 h were similar after LF or CAP. We concluded that, after LF, sugar excretion in 0-2 h urine may reflect both SI and colon permeability. Colonic permeability is reflected by urine sugar excretion between 6 and 24 h. CAP delivery reduces mannitol excreted at 0-6 h, compared with LF. The 0-5 or 6 h 2-SE urine likely reflects both SI and colon permeability; the higher LMR in the 8-24 h urine relative to 0-2 h urine should be interpreted with caution and does not mean that colon is more permeable than SI.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19614866      PMCID: PMC2802677          DOI: 10.1111/j.1365-2982.2009.01361.x

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  27 in total

1.  Transit of solids through the human colon: regional quantification in the unprepared bowel.

Authors:  M Proano; M Camilleri; S F Phillips; M L Brown; G M Thomforde
Journal:  Am J Physiol       Date:  1990-06

2.  Automated enzymatic assays for the determination of intestinal permeability probes in urine. 1. Lactulose and lactose.

Authors:  C A Northrop; P G Lunn; R H Behrens
Journal:  Clin Chim Acta       Date:  1990-02-28       Impact factor: 3.786

3.  Lactulose, 51Cr-labelled ethylenediaminetetra-acetate, L-rhamnose and polyethyleneglycol 400 [corrected] as probe markers for assessment in vivo of human intestinal permeability.

Authors:  D G Maxton; I Bjarnason; A P Reynolds; S D Catt; T J Peters; I S Menzies
Journal:  Clin Sci (Lond)       Date:  1986-07       Impact factor: 6.124

4.  A simple enzymatic method for the assay of urinary lactulose.

Authors:  R H Behrens; H Docherty; M Elia; G Neale
Journal:  Clin Chim Acta       Date:  1984-03-13       Impact factor: 3.786

5.  Automated enzymatic assays for the determination of intestinal permeability probes in urine. 2. Mannitol.

Authors:  P G Lunn; C A Northrop; A J Northrop
Journal:  Clin Chim Acta       Date:  1989-08-15       Impact factor: 3.786

6.  Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome.

Authors:  R C Spiller; D Jenkins; J P Thornley; J M Hebden; T Wright; M Skinner; K R Neal
Journal:  Gut       Date:  2000-12       Impact factor: 23.059

7.  Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators.

Authors:  T Piche; G Barbara; P Aubert; S Bruley des Varannes; R Dainese; J L Nano; C Cremon; V Stanghellini; R De Giorgio; J P Galmiche; M Neunlist
Journal:  Gut       Date:  2008-09-29       Impact factor: 23.059

8.  Impaired transit of chyme in chronic intestinal pseudoobstruction. Correction by cisapride.

Authors:  M Camilleri; M L Brown; J R Malagelada
Journal:  Gastroenterology       Date:  1986-09       Impact factor: 22.682

9.  A persistent defect in intestinal permeability in coeliac disease demonstrated by a 51Cr-labelled EDTA absorption test.

Authors:  I Bjarnason; T J Peters; N Veall
Journal:  Lancet       Date:  1983-02-12       Impact factor: 79.321

10.  Absorption of 51chromium-labeled ethylenediaminetetraacetate in inflammatory bowel disease.

Authors:  I Bjarnason; C O'Morain; A J Levi; T J Peters
Journal:  Gastroenterology       Date:  1983-08       Impact factor: 22.682

View more
  50 in total

1.  Urine sugars for in vivo gut permeability: validation and comparisons in irritable bowel syndrome-diarrhea and controls.

Authors:  Archana S Rao; Michael Camilleri; Deborah J Eckert; Irene Busciglio; Duane D Burton; Michael Ryks; Banny S Wong; Jesse Lamsam; Ravinder Singh; Alan R Zinsmeister
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-08-11       Impact factor: 4.052

2.  Effects of chenodeoxycholate and a bile acid sequestrant, colesevelam, on intestinal transit and bowel function.

Authors:  Suwebatu T Odunsi-Shiyanbade; Michael Camilleri; Sanna McKinzie; Duane Burton; Paula Carlson; Irene A Busciglio; Jesse Lamsam; Ravinder Singh; Alan R Zinsmeister
Journal:  Clin Gastroenterol Hepatol       Date:  2009-10-30       Impact factor: 11.382

Review 3.  Crosstalk at the mucosal border: importance of the gut microenvironment in IBS.

Authors:  Lena Öhman; Hans Törnblom; Magnus Simrén
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2014-12-02       Impact factor: 46.802

4.  Biomarkers of environmental enteric dysfunction are not consistently associated with linear growth velocity in rural Zimbabwean infants.

Authors:  Kuda Mutasa; Robert Ntozini; Mduduzi N N Mbuya; Sandra Rukobo; Margaret Govha; Florence D Majo; Naume Tavengwa; Laura E Smith; Laura Caulfield; Jonathan R Swann; Rebecca J Stoltzfus; Lawrence H Moulton; Jean H Humphrey; Ethan K Gough; Andrew J Prendergast
Journal:  Am J Clin Nutr       Date:  2021-05-08       Impact factor: 7.045

Review 5.  The impoverished gut--a triple burden of diarrhoea, stunting and chronic disease.

Authors:  Richard L Guerrant; Mark D DeBoer; Sean R Moore; Rebecca J Scharf; Aldo A M Lima
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-12-11       Impact factor: 46.802

6.  Kinetics of the histological, serological and symptomatic responses to gluten challenge in adults with coeliac disease.

Authors:  Daniel Leffler; Detlef Schuppan; Kumar Pallav; Robert Najarian; Jeffery D Goldsmith; Joshua Hansen; Toufic Kabbani; Melinda Dennis; Ciarán P Kelly
Journal:  Gut       Date:  2012-05-22       Impact factor: 23.059

7.  MicroRNA-29a regulates intestinal membrane permeability in patients with irritable bowel syndrome.

Authors:  QiQi Zhou; Wiley W Souba; Carlo M Croce; G Nicholas Verne
Journal:  Gut       Date:  2009-12-01       Impact factor: 23.059

8.  Night workers with circadian misalignment are susceptible to alcohol-induced intestinal hyperpermeability with social drinking.

Authors:  Garth R Swanson; Annika Gorenz; Maliha Shaikh; Vishal Desai; Thomas Kaminsky; Jolice Van Den Berg; Terrence Murphy; Shohreh Raeisi; Louis Fogg; Martha Hotz Vitaterna; Christopher Forsyth; Fred Turek; Helen J Burgess; Ali Keshavarzian
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-05-19       Impact factor: 4.052

9.  Association of HLA-DQ gene with bowel transit, barrier function, and inflammation in irritable bowel syndrome with diarrhea.

Authors:  Maria I Vazquez-Roque; Michael Camilleri; Thomas Smyrk; Joseph A Murray; Jessica O'Neill; Paula Carlson; Jesse Lamsam; Deborah Eckert; Denise Janzow; Duane Burton; Michael Ryks; Deborah Rhoten; Alan R Zinsmeister
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-10-04       Impact factor: 4.052

10.  A controlled trial of gluten-free diet in patients with irritable bowel syndrome-diarrhea: effects on bowel frequency and intestinal function.

Authors:  Maria I Vazquez-Roque; Michael Camilleri; Thomas Smyrk; Joseph A Murray; Eric Marietta; Jessica O'Neill; Paula Carlson; Jesse Lamsam; Denise Janzow; Deborah Eckert; Duane Burton; Alan R Zinsmeister
Journal:  Gastroenterology       Date:  2013-01-25       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.